Mechanism of macrophage mitochondrial transfer in CBNPs induced EndMT of pulmonary microvascular endothelial cells
- J Hazard Mater. 2026 Mar 1:505:141468. doi: 10.1016/j.jhazmat.2026.141468.
- 1. Department of Toxicology, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China.
- 2. Experimental Center, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China.
- 3. Occupational Health and Environmental Health, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China.
- 4. Department of Environmental Health, School of Public Health, Shanxi Medical University, Taiyuan 030001, PR China; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, PR China.
- 5. Occupational Health and Environmental Health, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China; Hebei Key Laboratory of Environment and Human Health, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China.
- 6. Department of Environmental Health, School of Public Health, Shanxi Medical University, Taiyuan 030001, PR China; MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, PR China. Electronic address: [email protected].
- 7. Department of Toxicology, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China; Hebei Key Laboratory of Environment and Human Health, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China; The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, Hebei 050017, PR China. Electronic address: [email protected].
Carbon black nanoparticles (CBNPs) have been identified as a potential contributing factor to idiopathic pulmonary fibrosis (IPF), though the specific mechanisms by which they induce endothelial-mesenchymal transition (EndMT) remain to be fully elucidated. The objective of this study was to ascertain whether CBNPs induce EndMT in pulmonary microvascular endothelial cells via PANoptosis-mediated mitochondrial transfer in alveolar macrophages (AMs). A mouse model of CBNPs inhalation exposure was established to evaluate pulmonary function, Collagen deposition, and EndMT biomarkers. Co-culture systems of alveolar macrophages cells (M-HS) and pulmonary microvascular endothelial cells (MPVECs) were employed to investigate the process by which PANoptosis induced mitochondrial transfer. Key mechanisms were validated using Western blot, qPCR, molecular docking, co-immunoprecipitation, and bioinformatics analyses. The results showed that CBNPs exposure significantly impaired pulmonary function, induced Collagen deposition, and activated EndMT. Conditioned media from CBNPs-treated M-HS triggered EndMT in MPVECs, mediated by the transfer of damaged mitochondria. Mechanistically, CBNPs suppressed the PINK1/Parkin Mitophagy pathway, driving PANoptosis in M-HS and subsequent released of dysfunctional mitochondria. IFI27 was identified as a critical regulator of PANoptosis, directly binding to PINK1 to exacerbate mitochondrial dysfunction. Silencing IFI27 alleviated PANoptosis and mitochondrial transfer, reversing the EndMT phenotype in MPVECs. Collectively, these findings indicated that CBNPs induced EndMT in MPVECs via mitochondrial transfer, with the IFI27-PINK1 axis regulating this transfer process. This mitochondrial transfer represents as a novel therapeutic target for CBNPs-induced IPF. Moreover, modulating the process of mitochondrial transfer with IFI27 as a regulatory factor mitigate nanotoxicity-driven pulmonary fibrotic progression.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease